Ibisqus Hospital Line

Ibisqus is an Italian pharmaceutical and medical device company specializing in the development and commercialization of hyaluronic acid-based products. The company's Hospital Line focuses on providing high-quality therapeutic solutions for orthopedics, ophthalmology, and dermatology, particularly for joint health and tissue repair. Ibisqus manages the entire lifecycle of its products, from research and development to manufacturing and distribution within the European market. Their portfolio includes intra-articular injections for viscosupplementation, ophthalmic viscoelastic devices for surgery, and advanced wound care treatments. The company is recognized for its high-purity sodium hyaluronate formulations which are used to treat conditions such as osteoarthritis and dry eye syndrome. Headquartered in Assago, Italy, Ibisqus serves as a key supplier to hospitals and specialized clinics across the region.